Author:
Zavalishina L. E.,Andreeva Yu. Yu.,Olyushina E. M.,Frank G. A.,Kuznetsova O. A.,Telezhnikova I. M.,Vinogradov I. I.,Moskvina L. V.
Publisher
Media Sphere Publishing Group
Subject
Pathology and Forensic Medicine
Reference13 articles.
1. Methods of measurement for tumor mutational burden in tumor tissue
2. Mutational landscape and significance across 12 major cancer types
3. Nemtsova MV, Mikhailenko DS, Kekeeva TV, Kuznetsova OA, Bashkatov SV, Kurynin RV, Popov AM, Popova OP, Shegai PV, Andreeva YuYu, Alekseev BYa, Enikeev ME, Alyaev YuG, Karyakin OB, Rusakov IG, Frank GA, Zaletaev DV. Molecular genetic markers in oncourology. Molekulyarnaya meditsina. 2007;3:43-54. (In Russ.)
4. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
5. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献